Cardio-Obstetrics
Definition
Cardio-obstetrics (also called the "pregnancy heart team") is a multidisciplinary clinical model integrating cardiology with obstetric specialties to manage cardiovascular disease (CVD) during pregnancy, delivery, and up to 1 year postpartum. CVD is the leading cause of pregnancy-related mortality in the United States, rising from 7.2 to 17.2 deaths per 100,000 live births between 1987 and 2015. Preconception counseling, antepartum monitoring, peripartum management, and postpartum cardiovascular follow-up are all within the scope of the cardio-obstetrics team.
Key Concepts
Team Composition and Scope of Care
- The cardio-obstetrics team typically includes: obstetricians, cardiologists, anesthesiologists, maternal-fetal medicine (MFM) specialists, geneticists, neurologists, nurses, and pharmacists sources/cv-pregnancy-aha-2020 (rating: high)
- Scope spans the full reproductive care continuum: preconception → antepartum → peripartum → postpartum → up to 1 year postpartum
- Team jointly develops a comprehensive management strategy including expected events, shared decision-making, medication safety review, and delivery planning
Preconception Counseling
- Essential for all women with preexisting CVD or history of preeclampsia prior to subsequent pregnancy
- Core elements: individual maternal CV risk estimation, medication review (ACEi/ARBs are teratogenic — must be replaced before pregnancy), folic acid assessment, nutritional status, contraception counseling sources/cv-pregnancy-aha-2020 (rating: high)
- Early identification of prohibitive-risk conditions allows informed shared decision-making
Maternal Risk Stratification — Modified WHO Classification
- The modified WHO classification is the only prospectively validated method for estimating individual maternal cardiovascular risk in women with CVD contemplating pregnancy sources/cv-pregnancy-aha-2020 (rating: high)
- Other risk models have been developed but none are prospectively validated
- All validated models include: prior CVD event, history of arrhythmia, prior heart failure, poor functional class, resting cyanosis, anticoagulant use, mechanical valve
- Prohibitive/highest-risk conditions (WHO Class IV — pregnancy often discouraged):
- Pulmonary arterial hypertension (PAH)
- Severe ventricular dysfunction
- Severe left-sided heart obstruction (aortic stenosis, mitral stenosis)
- Significant aortic dilatation with underlying connective tissue disease (Marfan syndrome, Loeys-Dietz)
Antepartum Monitoring
- Frequency of monitoring and team composition determined by modified WHO risk class sources/cv-pregnancy-aha-2020 (rating: high)
- Echo assessment of aortic dimensions in aortopathy: every 12 weeks (low risk) or monthly (high risk)
- Hemodynamic and structural changes in pregnancy must be accounted for when interpreting imaging results (e.g., physiological increases in valve velocities)
Delivery Planning
- Vaginal delivery preferred for most women with heart disease; cesarean reserved for obstetric indications or specific cardiovascular circumstances (e.g., fully anticoagulated with VKA at labor) sources/cv-pregnancy-aha-2020 (rating: high)
- ACOG recommends elective induction 39–40 weeks for cardiac disease patients without spontaneous onset
- WHO Class IV decisions made on a case-by-case basis by the high-risk team
Postpartum Care and Contraception
- Peripartum admission is the ideal time for: future pregnancy discussion, contraception planning, late CVD risk counseling sources/cv-pregnancy-aha-2020 (rating: high)
- IUD (copper or hormonal) and progestin-only subdermal implants can be placed immediately postpartum
- Combined hormonal contraception (CHC) unreasonable (risk outweighs benefit) in: DVT/PE history, hypertension with vascular disease, PPCM (including mild systolic dysfunction), complicated valvular disease, ischemic heart disease
- Patients with APOs warrant fourth-trimester follow-up with aggressive risk factor modification; APOs are CVD risk-enhancing conditions per the 2018 multisociety cholesterol guideline
Specific Conditions Requiring Cardio-Obstetrics Team
| Condition | Key Consideration |
|---|---|
| PPCM | Bromocriptine adjunctive; prognosis by EF; contraception before discharge |
| HCM | 23% HF/arrhythmia risk; avoid diuretics aggressively (need preload) |
| Mechanical valves | Warfarin ≤5 mg/d or LMWH (anti-Xa 0.8–1.2); DOACs avoided |
| Aortopathy | WHO III–IV; echo every 12 weeks to monthly; β-blockers |
| LQTS | β-blockade throughout pregnancy; high postpartum risk |
| PAH | WHO Class IV; pregnancy often discouraged |
| Ischemic heart disease | SCAD: conservative management; atherosclerotic STEMI: PCI |
Contradictions / Open Questions
- Whether referral to dedicated cardio-obstetrics centres improves hard maternal/fetal outcomes over general obstetric care is not established — most evidence is observational sources/cv-pregnancy-aha-2020 (rating: high)
- Optimal timing and frequency of antepartum monitoring for lower-risk (WHO Class I–II) conditions is not defined by RCT data
- Postpartum follow-up duration (beyond 6 weeks) is not standardized; fourth-trimester (12-week) protocols vary by institution
Connections
- Related to entities/Peripartum-Cardiomyopathy — PPCM is the cardiomyopathy most specifically managed by the cardio-obstetrics team
- Related to concepts/Hypertensive-Disorders-of-Pregnancy — HDP team management; postpartum BP surveillance
- Related to concepts/Preeclampsia — preeclampsia requires immediate cardio-obstetrics involvement
- Related to concepts/Adverse-Pregnancy-Outcomes — APOs mandate fourth-trimester CVD risk follow-up
- Related to concepts/LQTS-Pregnancy-Management — LQTS-specific arrhythmia risk in pregnancy and postpartum
- Related to entities/Maternal-Health-Disparities — racial/ethnic mortality disparities in maternal CVD
- Related to entities/Hypertension — antihypertensive management in pregnancy and postpartum